No abstract available
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
MeSH terms
-
Administration, Oral
-
Age Factors
-
Bosentan / administration & dosage
-
Bosentan / therapeutic use
-
Drug Therapy, Combination
-
Endothelin Receptor Antagonists / administration & dosage
-
Endothelin Receptor Antagonists / therapeutic use*
-
Female
-
Humans
-
Hypertension, Pulmonary / drug therapy*
-
Hypertension, Pulmonary / mortality
-
Male
-
Middle Aged
-
Phenylpropionates / administration & dosage
-
Phenylpropionates / therapeutic use
-
Phosphodiesterase 5 Inhibitors / administration & dosage
-
Phosphodiesterase 5 Inhibitors / therapeutic use*
-
Pyridazines / administration & dosage
-
Pyridazines / therapeutic use
-
Pyrimidines / administration & dosage
-
Pyrimidines / therapeutic use
-
Retrospective Studies
-
Sildenafil Citrate / administration & dosage
-
Sildenafil Citrate / therapeutic use
-
Sulfonamides / administration & dosage
-
Sulfonamides / therapeutic use
-
Tadalafil / administration & dosage
Substances
-
Endothelin Receptor Antagonists
-
Phenylpropionates
-
Phosphodiesterase 5 Inhibitors
-
Pyridazines
-
Pyrimidines
-
Sulfonamides
-
Tadalafil
-
Sildenafil Citrate
-
ambrisentan
-
Bosentan
-
macitentan